Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

[1] Cooper JS(1999)Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 281 1623-1627

[2] Guo MD(1992)Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1593-1598

[3] Herskovic A(1997)Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study J Clin Oncol 15 277-284

[4] Macdonald JS(1996)Improving the quality of reporting of randomized controlled trials. The CONSORT statement JAMA 276 637-639

[5] Martenson JA(1999)Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus J Clin Oncol 17 2915-2921

[6] Al-Sarraf M(2003)Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus Br J Cancer 88 18-24

[7] Byhardt R(2005)Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer Jpn J Clin Oncol 35 316-323

[8] Russell AH(2003)Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus J Clin Oncol 21 2697-2702

[9] Beitler JJ(2006)Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma J Gastroenterol 41 425-432

[10] Spencer S(2009)Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy Adv Drug Deliv Rev 61 388-401

[1] Cooper JS(1999)Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 281 1623-1627

[2] Guo MD(1992)Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1593-1598

[3] Herskovic A(1997)Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study J Clin Oncol 15 277-284

[4] Macdonald JS(1996)Improving the quality of reporting of randomized controlled trials. The CONSORT statement JAMA 276 637-639

[5] Martenson JA(1999)Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus J Clin Oncol 17 2915-2921

[6] Al-Sarraf M(2003)Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus Br J Cancer 88 18-24

[7] Byhardt R(2005)Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer Jpn J Clin Oncol 35 316-323

[8] Russell AH(2003)Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus J Clin Oncol 21 2697-2702

[9] Beitler JJ(2006)Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma J Gastroenterol 41 425-432

[10] Spencer S(2009)Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy Adv Drug Deliv Rev 61 388-401